Clinical Trials Directory

Trials / Completed

CompletedNCT00074646

Phase I Trial of CC-8490 for the Treatment of Subjects With Recurrent/Refractory High-Grade Gliomas

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
36 (planned)
Sponsor
Celgene Corporation · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Phase I trial of CC-8490 for the treatment of subjects with recurrent/refractory high-grade gliomas

Conditions

Interventions

TypeNameDescription
DRUGCC-8490

Timeline

Start date
2003-12-01
Completion
2005-06-01
First posted
2003-12-19
Last updated
2007-01-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00074646. Inclusion in this directory is not an endorsement.